These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin. Silva R; Torrent T; Loureiro R; Travassos A; de Abreu JR Eur J Ophthalmol; 2004; 14(5):434-7. PubMed ID: 15506607 [TBL] [Abstract][Full Text] [Related]
83. Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years? Voykov B; Gelisken F; Inhoffen W; Voelker M; Bartz-Schmidt KU; Ziemssen F Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):543-50. PubMed ID: 20111971 [TBL] [Abstract][Full Text] [Related]
85. Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration. Parmeggiani F; Costagliola C; Semeraro F; Romano MR; Rinaldi M; Gallenga CE; Serino ML; Incorvaia C; D'Angelo S; De Nadai K; Dell'Omo R; Russo A; Gemmati D; Perri P Int J Mol Sci; 2015 Aug; 16(8):19796-811. PubMed ID: 26307969 [TBL] [Abstract][Full Text] [Related]
86. Photodynamic therapy in young patients. Lam A; Lee HC; Ho AC; Regillo CD; McNamara JA; Fineman MD Ophthalmic Surg Lasers Imaging; 2006; 37(3):182-9. PubMed ID: 16749253 [TBL] [Abstract][Full Text] [Related]
87. Photodynamic therapy for choroidal neovascularization in patients with multifocal choroiditis and panuveitis. Gerth C; Spital G; Lommatzsch A; Heiligenhaus A; Pauleikhoff D Eur J Ophthalmol; 2006; 16(1):111-8. PubMed ID: 16496254 [TBL] [Abstract][Full Text] [Related]
88. Photodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditis. Oliveira LB; Reis PA Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):1028-30. PubMed ID: 15064953 [TBL] [Abstract][Full Text] [Related]
89. Gradual healing of macular retinoschisis after photodynamic therapy for choroidal neovascularization in pathological myopia eyes. Qi Y; Zhang Y; Yu J; Liu W; Xu G Photodiagnosis Photodyn Ther; 2020 Dec; 32():102021. PubMed ID: 32977067 [TBL] [Abstract][Full Text] [Related]
90. Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome. Shah GK; Blinder KJ; Hariprasad SM; Thomas MA; Ryan EH; Bakal J; Sharma S Retina; 2005 Jan; 25(1):26-32. PubMed ID: 15655437 [TBL] [Abstract][Full Text] [Related]
91. Photodynamic therapy for choroidal neovascularization in pediatric patients. Giansanti F; Virgili G; Varano M; Tedeschi M; Rapizzi E; Giacomelli G; Menchini U Retina; 2005; 25(5):590-6. PubMed ID: 16077356 [TBL] [Abstract][Full Text] [Related]
92. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Busquets MA; Shah GK; Wickens J; Callanan D; Blinder KJ; Burgess D; Grand MG; Holekamp NM; Boniuk I; Joseph DP; Thomas MA; Fish E; Bakal J; Hollands H; Sharma S Retina; 2003 Jun; 23(3):299-306. PubMed ID: 12824828 [TBL] [Abstract][Full Text] [Related]
93. Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy. Gelisken F; Lafaut BA; Inhoffen W; Voelker M; Grisanti S; Bartz-Schmidt KU Br J Ophthalmol; 2004 Feb; 88(2):207-11. PubMed ID: 14736776 [TBL] [Abstract][Full Text] [Related]
94. [Comparison of macular limited translocation and photodynamic therapy for management of choroidal neovascularization in degenerative myopia: a retrospective study]. Dumas S; Glacet-Bernard A; Haddad WM; Razavi S; Roquet W; Coscas G; Soubrane G J Fr Ophtalmol; 2006 Nov; 29(9):980-9. PubMed ID: 17114990 [TBL] [Abstract][Full Text] [Related]
95. Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy. Wang LK; Kansal S; Pulido JS Am J Ophthalmol; 2002 Nov; 134(5):790-2. PubMed ID: 12429271 [TBL] [Abstract][Full Text] [Related]
96. Long-term results of photodynamic therapy for choroidal neovascularization in Japanese patients with pathologic myopia. Hayashi K; Ohno-Matsui K; Shimada N; Moriyama M; Hayashi W; Wang J; Yoshida T; Tokoro T; Mochizuki M Am J Ophthalmol; 2011 Jan; 151(1):137-147.e1. PubMed ID: 20970774 [TBL] [Abstract][Full Text] [Related]
97. Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia. Srivastava SK; Sternberg P Retina; 2002 Oct; 22(5):669-71. PubMed ID: 12441742 [No Abstract] [Full Text] [Related]
98. Photodynamic therapy for choroidal neovascularization in eyes with retinal vascular disorders. Eandi CM; Piccolino FC; Ventre L; Grignolo FM Retina; 2002 Aug; 22(4):495-8. PubMed ID: 12172119 [No Abstract] [Full Text] [Related]
99. Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia. Ohno-Matsui K; Moriyama M; Hayashi K; Mochizuki M Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1363-6. PubMed ID: 16523294 [TBL] [Abstract][Full Text] [Related]
100. Photodynamic therapy outcomes in a case of macular choroidal neovascularization secondary to Candida endophthalmitis. Tedeschi M; Varano M; Schiano Lomoriello D; Scassa C; Parisi V Eur J Ophthalmol; 2007; 17(1):124-7. PubMed ID: 17294393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]